About the study
Our goal is to identify effective, safe, affordable, and evidence-based medications so they can be accessed by the community
Reduce hospitalizations, reduce the burden on hospitals and ICUs, and help people have fewer symptoms and feel better faster
Open to Canadian residents (18+ years of age) who are within the first 5 days of experiencing COVID-19 symptoms
Directly influence standards of care for COVID-19 infection in community settings in Canada and around the world
Supported by $10-million dollars in grants from the Canadian Institutes of Health Research and Health Canada
30+ partner organizations engaging diverse populations across Canada to evaluate the clinical- and cost-effectiveness of medications for COVID-19
Participate in our study.
Participate in our study
The CanTreatCOVID trial relies on volunteers, often referred to as participants, to help us better understand the effectiveness of medications for mild to moderate COVID-19. The study is open to Canadians (18+ years of age) who are within the first 5 days of experiencing symptoms. Enrollment coming soon!
